VSN16R
VSN16R (SPG601) is a drug which acts as an opener of BK Ca large-conductance, calcium-activated potassium channels.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
VSN16R (SPG601) is a drug which acts as an opener of BK Ca large-conductance, calcium-activated potassium channels. It is similar in chemical structure to some cannabinoid derivatives such as methanandamide and CB-86, and was originally thought to be an atypical cannabinoid compound, but pharmacological studies showed it to be inactive at both cannabinoid receptors and related receptors such as GPR55, and eventually it was found to be a selective BK Ca channel opener.
It has neuroprotective effects and reduces muscle spasticity, and is being researched as a potential therapeutic agent for the treatment of Fragile X syndrome.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370310328 under CC BY-SA 4.0; modifications have been made.